Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study Alejandra García-NovoaBenigno Acea-NebrilJoaquin Mosquera Oses Breast Oncology 28 July 2020 Pages: 958 - 967
Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy Astrid Botty Van den BrueleJessica LaveryMelissa L. Pilewskie Breast Oncology 19 August 2020 Pages: 968 - 974
Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels Libo YangDongli LuHong Bu Breast Oncology 13 August 2020 Pages: 975 - 984
Smartphone Global Positioning System (GPS) Data Enhances Recovery Assessment After Breast Cancer Surgery Nikhil PandaIan SolskyAlex B. Haynes Breast Oncology 18 August 2020 Pages: 985 - 994
The Landmark Series: Chemotherapy for Non-Metastatic Colon Cancer Salvador AlonsoLeonard Saltz Colorectal Cancer 23 November 2020 Pages: 995 - 1001
Vesicovaginal Fistula Repair by Modified Martius Flap: A Step-by-Step Surgical Technique Video Tiermes MarinaVíctor LagoSantiago Domingo Gynecologic Oncology 14 August 2020 Pages: 1002 - 1006
Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick Melanomas Dale HanGang HanJonathan S. Zager Melanoma 10 June 2020 Pages: 1007 - 1016
ASO Author Reflections: Sentinel Lymph Node Biopsy is Prognostic in the Thickest Melanoma Cases and Should be Performed for Thick Melanomas Steven MorrisonDale Han ASO Author Reflections 12 June 2020 Pages: 1017 - 1018
The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC) Linde M. van VeenendaalEduardo BertolliAlexander C. J. van Akkooi Melanoma 11 June 2020 Pages: 1019 - 1028
Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy Sophia HaywoodJennifer GariochMarc Moncrieff Melanoma Open access 15 June 2020 Pages: 1029 - 1038
The Landmark Series: Pancreatic Neuroendocrine Tumors Jordan M. CloydGeorge A. Poultsides Pancreatic Tumors 18 September 2020 Pages: 1039 - 1049
ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors Jordan M. CloydGeorge A. Poultsides ASO Author Reflections 24 September 2020 Pages: 1050 - 1051
The Landmark Series: Mitigation of the Postoperative Pancreatic Fistula George Van Buren IICharles M. Vollmer Jr. Pancreatic Tumors 21 October 2020 Pages: 1052 - 1059
Elucidating the Causes of Improved Survival in Clinical Trials of Randomized Adjuvant Pancreatic Ductal Adenocarcinoma (PDAC) Andre AlabdAndrew AlabdJordan M. Winter Pancreatic Tumors 23 September 2020 Pages: 1060 - 1068
A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey Zineb CherkaouiCristians GonzálezIHU-VBHC Working Group Pancreatic Tumors 08 June 2020 Pages: 1069 - 1078
Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma M. KorrelS. Loffor the European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS) Pancreatic Tumors Open access 25 June 2020 Pages: 1079 - 1087
Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma George MolinaThomas E. ClancyJiping Wang Pancreatic Tumors 10 July 2020 Pages: 1088 - 1096
Relationship between Cancer Diagnosis and Complications Following Pancreatoduodenectomy for Duodenal Adenoma Nina L. EngDanielle E. MustinDavid A. Kooby Pancreatic Tumors 20 July 2020 Pages: 1097 - 1105
Distal Pancreatectomy with Celiac Axis Resection (Modified Appleby Procedure) and Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma After FOLFIRINOX Chemotherapy and Chemoradiation Therapy Pierre-Emmanuel ColomboFrançois QuenetGuillaume Carrier Pancreatic Tumors 25 June 2020 Pages: 1106 - 1108
Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin Mohammad AdilehJonathan B. YuvalGarrett M. Nash Peritoneal Surface Malignancy 25 August 2020 Pages: 1109 - 1117
Total Parietal Peritonectomy Can Be Performed with Acceptable Morbidity for Patients with Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: Results From a Prospective Multi-centric Study Aditi BhattPraveen KammarSanket Mehta Peritoneal Surface Malignancy 03 August 2020 Pages: 1118 - 1129
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study T. Susanna MeijerMark C. BurgmansAlexander L. Vahrmeijer Peritoneal Surface Malignancy Open access 05 August 2020 Pages: 1130 - 1141
Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group Anna PaioliSilvia StacchiottiAlessandro Gronchi Sarcoma 22 June 2020 Pages: 1142 - 1150
Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution Andraz PerhavecSalvatore ProvenzanoMarco Fiore Sarcoma 06 July 2020 Pages: 1151 - 1157
Orthopedic Surgical Treatment and Perioperative Complications in Multiple Myeloma Bone Disease: Analysis of a Series (2009–2018) María Galán-OllerosJavier MarcoJuan Luis Cebrián-Parra Sarcoma 13 July 2020 Pages: 1158 - 1166
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas Alessandro VanoliFederica GrilloAntonio Di Sabatino Translational Research Open access 05 August 2020 Pages: 1167 - 1177
Prognostic Significance of Circulating Tumor Cells with Mesenchymal Phenotypes in Patients with Gastric Cancer: A Prospective Study Yui IshiguroHideyasu SakihamaAkinobu Taketomi Translational Research 07 August 2020 Pages: 1178 - 1186
Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer Ann M. MillerCaitlin D. Lemke-MiltnerCarlos H. F. Chan Translational Research and Biomarkers 14 May 2020 Pages: 1187 - 1197
Distal Gastrectomy with Billroth II Reconstruction is Associated with Oralization of Gut Microbiome and Intestinal Inflammation: A Proof-of-Concept Study Angela HorvathAugustinas BausysKestutis Strupas Translational Research and Biomarkers Open access 05 June 2020 Pages: 1198 - 1208
Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Akihiko OkamuraSatoru MatsudaMasayuki Watanabe Translational Research and Biomarkers 10 June 2020 Pages: 1209 - 1216
CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma Tomonori YoshidaTakehiko YokoboriKen Shirabe Translational Research and Biomarkers 11 June 2020 Pages: 1217 - 1227
Correlation Between Immunoinflammatory Measures and Periostin Expression in Esophageal Squamous Cell Carcinoma: A Single-Center, Retrospective Cohort Study Yusuke IshibashiHironori TsujimotoHideki Ueno Translational Research and Biomarkers 01 July 2020 Pages: 1228 - 1237
Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China Ning LiuFeng QuWeidong Gan Urologic Oncology Open access 06 July 2020 Pages: 1238 - 1246
Conditional Survival and Time of Biochemical Recurrence of Localized Prostate Cancer in Japanese Patients Undergoing Laparoscopic Radical Prostatectomies Masayoshi KawakamiMasanori HasegawaAkira Miyajima Urologic Oncology 10 July 2020 Pages: 1247 - 1253
Three Different Learning Curves Have an Independent Impact on Perioperative Outcomes After Robotic Partial Nephrectomy: A Comparative Analysis Philip ZeuschnerIrmengard MeyerMartin Janssen Urologic Oncology Open access 24 July 2020 Pages: 1254 - 1261